Eikon Therapeutics, Inc. (EIKN)
Eikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States.
$9.19-0.04%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-36.6%
The outlook
Eikon Therapeutics, Inc. currently reads as leaning bearish based on below its 50- & 200-day averages, 14% of the way from its 52-week low to high, avg target +170% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range14% of the way from its 52-week low to high
Price targetAvg target +170% vs current price
Analyst price target
~12-month · 5 analysts$24.80average target+169.9% vs now
Now $9.19
Low $5.00High $32.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$497.5M
52-wk high
$17.40
52-wk low
$7.90
50-day avg
$10.14
200-day avg
$11.22
Trailing P/E
—